Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study

Huang, J. and Li, M. and Li, J. and Tang, Y. and Shi, W.